Loading...
Loading...
Savient Pharma
SVNT announced today that David Meeker, M.D., President and Chief
Executive Officer of Genzyme, a Sanofi Company, has been elected to Savient's
Board of Directors, effective January 7, 2013. In addition, Savient announced
the resignation from the Company's Board of William F. Owen, Jr., M.D., who is
relocating to Qatar to serve as Chief Executive Officer of the Sidra Medical
and Research Center, a groundbreaking medical, research and education
institution that focuses on the health and wellbeing of women and children in
Doha, Qatar. With the election of Dr. Meeker and the departure of Dr. Owen,
the number of Savient Board members remains seven.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Posted In: NewsManagement
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in